General rehabilitation principles, quality of life and outcome assessment in patients with stroke [İnmeli hastalarda genel rehabilitasyon prensipleri, yasam kalitesi ve son durum degerlendirmesi]

Stroke has a major health problem affecting all aspects of an individual's life. Its long-term consequences resulting in neurological impairment and functional disability have a substantial impact on quality of life. In this systematic literature general principles of rehabilitation, quality of life and last situation in post-stroke assessment are reviewed according to the recent studies in patients with stroke

Comments on “Prevalence of shoulder morbidity after treatment for breast Cancer in South Africa”

[No abstract available

Fibromyalgia syndrome from the perspective of neuropathic pain [Nöropatik agri açisindan fibromyalji sendromu]

PubMed ID: 18338273Fibromyalgia syndrome (FMS) is one of the several chronic pain syndromes and have been proposed to reflect some primary abnormality of the nervous system. Patients with FMS display common clinical features with neuropathic pain. The responsible mechanisms for symptoms and signs are still unknown. Mounting evidence was shown for central pain processing abnormalities in almost all FMS patients. These anomalies including hyperalgesia, allodynia, abnormal activation of pain-related brain regions and abnormal temporal summation of second pain in FMS patients strongly indicate a neuropathic pain syndrome. This new information led to the proposal that FMS may be a neuropathic pain syndrome maintained by central nervous system sensitization and sympathetic hyperactivity. This different perspective on FMS opens new avenues for research and treatment. In this review, a synthesis of the information about how FMS is related to neuropathic pain syndromes is provided

Reason of progressive loss of function and frailty in elderly: Sarcopenia [Yaşlilarda progresi·f yeti· kaybi ve kirilganlik nedeni·: Sarkopeni·]

Sarcopenia is a multi-factorial and complex condition that can be defined as loss of mass, strength, quality, and function in muscles associated with age. While there are still research studies in progress, the primary cause of sarcopenia has not yet been defined. To diagnose sarcopenia, muscle mass, muscle strength, and physical performance should be estimated. However, the lack of diagnostic criteria to identify patients with sarcopenia hinders potential management options. With advances in molecular physiology, potential medicines that can make changes in skeletal muscles are currently being defined. Unfortunately, the molecules in the literature are not of the type that meet our expectations yet, due to their side effects and the lack of evidence, as there is insufficient data on the mechanism, efficacy, and safety of pharmacologic treatments. Resistive exercises and nutritional support prophylaxes are useful in the treatment of sarcopenia; therefore, health professionals have much work to do to plan personal, or when necessary, community- or home-based, exercise programs. Considered one of the geriatric symptoms, sarcopenia is important for both its health and economic consequences. Therefore, in order to bring attention to the diagnosis and treatment of sarcopenia in clinical practice, we deal with its different aspects in this review